| Not Yet Recruiting | Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world Acute Lymphobkastic Leukemia, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | — | 2026-04-02 |
| Not Yet Recruiting | Identification of BCR::ABL1 Mutations by Digital PCR in CML Chronic Myeloid Leukemia (CML) | N/A | 2026-02-01 |
| Not Yet Recruiting | Momelotinib Effectiveness in Myelofibrosis Myelofibrosis (MF) | — | 2026-01-02 |
| Not Yet Recruiting | Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions Acute Myeloid Leukemia, NPM1 Mutation | — | 2025-11-01 |
| Not Yet Recruiting | Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma Multiple Myleoma, Multiple Myeloma in Relapse, Multiple Myeloma Refractory | Phase 2 | 2025-11-01 |
| Recruiting | Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Multiple Myeloma | — | 2025-08-29 |
| Recruiting | Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial) Acute Myeloid Leukemia, AML, Adult, Acute Myeloid Leukemia, Adult | — | 2025-07-11 |
| Recruiting | PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML CML, Chronic Phase, Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia, BCR/ABL-Positive | Phase 2 | 2025-06-26 |
| Not Yet Recruiting | Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia Acute Myeloid Leukemia, FLT3 Gene Mutation, Adult AML | Phase 2 | 2025-06-01 |
| Recruiting | Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment Multiple Myeloma, Diagnosis | — | 2025-03-10 |
| Recruiting | HRQoL and Financial Toxicity in Patients With VEXAS Syndrome VEXAS | — | 2024-11-01 |
| Active Not Recruiting | Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program T-Lymphocytic Leukemia, Acute | Phase 2 | 2024-10-17 |
| Not Yet Recruiting | Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010 Primary Immune Thrombocytopenia | — | 2024-09-01 |
| Not Yet Recruiting | Biological and Clinical Efficacy of Shingrix in Patients With CLL Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL-like MBL | N/A | 2024-08-01 |
| Not Yet Recruiting | Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax AML, Adult, Minimal Residual Disease | N/A | 2024-07-01 |
| Not Yet Recruiting | Real-world Ruxolitinib Experience in PV Polycythemia Vera | — | 2024-07-01 |
| Not Yet Recruiting | Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Rea Chronic Lymphocytic Leukemia | — | 2024-05-01 |
| Recruiting | Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO Acute Lymphoblastic Leukemia, Infections, Bacterial Infections | — | 2024-04-04 |
| Unknown | Real World Evidence of Fedratinib Effectiveness in MF Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | — | 2024-01-29 |
| Unknown | Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study B-cell Non Hodgkin Lymphoma, Relapse, Refractory Lymphoma | — | 2023-12-22 |
| Recruiting | Novel Approaches to Target MECOM/EVI1 in AML AML, Adult | N/A | 2023-12-13 |
| Recruiting | Biologic Characterization of Patients With ITP Immune Thrombocytopenia | N/A | 2023-11-27 |
| Recruiting | Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2023-11-24 |
| Unknown | Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis Wit Chronic Lymphocytic Leukemia, Indolent B-Cell Non-Hodgkin Lymphoma, COVID-19 | — | 2023-09-12 |
| Active Not Recruiting | Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD T High Risk CLL, Chronic Lymphocytic Leukemia | Phase 2 | 2023-07-21 |
| Completed | Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP ITP - Immune Thrombocytopenia, Chronic ITP, Refractory ITP | — | 2023-05-05 |
| Active Not Recruiting | Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients Chemotherapy, Leukemia, Acute Lymphoblastic | Phase 2 | 2022-10-05 |
| Unknown | Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluati Immune Thrombocytopenia, ITP, Covid19 | — | 2022-08-22 |
| Unknown | Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell T DLBCL - Diffuse Large B Cell Lymphoma | — | 2022-06-29 |
| Unknown | Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Mye Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation | Phase 2 | 2022-03-01 |
| Active Not Recruiting | Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combinati Acute Myeloid Leukemia | Phase 2 | 2021-12-03 |
| Recruiting | Study on the Diagnosis and Management of CLL in Italy by GIMEMA Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type | — | 2021-10-13 |
| Unknown | Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients CLL, Chronic Lymphocytic Leukemia | N/A | 2021-10-01 |
| Completed | Use of nMoABs for the Treatment of COVID-19 in Patients With HM. Covid19, Hematological Malignancy | — | 2021-09-30 |
| Active Not Recruiting | Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL | Phase 3 | 2021-09-08 |
| Active Not Recruiting | Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches Acute Myeloid Leukemia | N/A | 2021-06-09 |
| Unknown | Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL T Acute Lymphoblastic Leukemia, Early T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma | N/A | 2021-05-19 |
| Active Not Recruiting | Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse | Phase 2 | 2021-05-04 |
| Unknown | LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study Langerhans Cell Histiocytosis | — | 2021-03-15 |
| Completed | Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated Wit Acute Myeloid Leukemia | — | 2021-02-23 |
| Terminated | Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 2 | 2021-02-16 |
| Recruiting | Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients Myelodysplastic Syndromes | N/A | 2021-02-12 |
| Recruiting | Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms Acute Myeloid Leukemia, Familial Acute Myeloid Leukemia, Myelodysplastic Syndromes | — | 2020-12-16 |
| Unknown | An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Progra Hematologic Malignancies | — | 2020-12-02 |
| Recruiting | Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT) High-risk MDS | Phase 3 | 2020-11-27 |
| Recruiting | Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML Acute Myeloid Leukemia | Phase 3 | 2020-09-24 |
| Recruiting | Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clin Chronic Lymphocytic Leukemia, Relapse Leukemia, Refractory Leukemia | — | 2020-07-24 |
| Terminated | The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated Large-B-cell Diffuse Lymphoma, Chronic Lymphoid Leukemia | Phase 2 | 2020-07-07 |
| Terminated | Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia | Phase 2 | 2020-06-25 |
| Active Not Recruiting | Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY). Myeloproliferative Neoplasm | — | 2020-05-29 |
| Unknown | AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance Acute Myeloid Leukemia With FLT3/ITD Mutation | Phase 3 | 2020-04-24 |
| Unknown | Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Le Acute Promyelocytic Leukemia | — | 2020-04-14 |
| Unknown | Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia Acute Lymphoid Leukemia | Phase 2 | 2019-10-30 |
| Unknown | Long-term Outcomes for Acute Myeloid Leukemia Patients Acute Myeloid Leukemia | — | 2019-05-16 |
| Unknown | Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia | — | 2019-05-10 |
| Terminated | Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | — | 2019-03-19 |
| Completed | Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab Chronic Lymphocytic Leukemia | — | 2019-02-06 |
| Completed | The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib Chronic Lymphocytic Leukemia | — | 2018-11-28 |
| Completed | Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Chronic Myeloid Leukemia | Phase 2 | 2018-10-31 |
| Active Not Recruiting | Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leuke Acute Myeloid Leukemia | Phase 2 | 2018-10-26 |
| Unknown | Investigation on a Dynamic Cohort of Italian Patients With Active ITP Idiopathic Thrombocytopenic Purpura | — | 2018-10-15 |
| Completed | Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia Acute Lymphoid Leukemia, Philadelphia Chromosome-Negative B-Cell Precursor | Phase 2 | 2018-06-08 |
| Active Not Recruiting | Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma Multiple Myeloma | — | 2017-11-13 |
| Completed | Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid Leukemia AML, Adult | — | 2017-10-31 |
| Unknown | Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia Chronic Myeloid Leukemia | — | 2017-08-03 |
| Unknown | D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leuk Acute Lymphoblastic Leukemia | Phase 2 | 2017-05-31 |
| Unknown | Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy Acute Promyelocytic Leukemia | — | 2017-03-27 |
| Completed | Bosutinib in Elderly Chronic Myeloid Leukemia Chronic Myeloid Leukemia | Phase 2 | 2016-11-17 |
| Unknown | Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia Chronyc Myeloid Leukemia | Phase 4 | 2016-11-11 |
| Terminated | Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Im Chronic Myeloid Leukemia, Chronic Phase, Adults | Phase 2 | 2016-06-23 |
| Completed | Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytope Immune Thrombocytopenia | — | 2016-04-01 |
| Completed | Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Chronic Lymphocytic Leukemia | — | 2016-03-01 |
| Completed | Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia Primacy Immune Thrombocytopenia | Phase 2 | 2016-02-24 |
| Completed | Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia Chronic Lymphocytic Leukemia | — | 2016-02-01 |
| Terminated | Retrospective Evaluation of CML Patients in the National Compassionate Program Chronic Myeloid Leukemia, Philadelphia Positive | — | 2015-12-22 |
| Completed | Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic L Leukemia, Lymphoblastic, Chronic | Phase 2 | 2015-10-01 |
| Completed | Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leu Chronic Lymphocyte Leukemia, Adult Patients | Phase 2 | 2015-03-02 |
| Completed | Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Pa Acute Lymphoblastic Leukemia, Complete Hematologic Remission (CHR), Persistent/Recurrent Minimal Residual Disease (MRD) | Phase 1 | 2015-01-28 |
| Unknown | LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients Chronic Myeloid Leukemia | — | 2014-09-11 |
| Completed | Occupational Status and Hematological Disease Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myelodysplastic Syndrome | — | 2014-09-08 |
| Completed | MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate Untreated Philadelphia Positive Acute Lymphoblastic Leukemia, De Novo, Secondary | Phase 2 | 2014-05-20 |
| Completed | TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients. Adult Patients, Immune Primary Thrombocytopenia, Splenectomy | — | 2014-05-14 |
| Completed | Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients Myelodysplastic Syndrome | — | 2014-03-01 |
| Unknown | Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib Chronic Myeloid Leukemia | — | 2014-01-28 |
| Completed | Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy B-cell Lymphoid Leukemia, Young Patients | Phase 2 | 2013-11-05 |
| Unknown | Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients CLL, B-cell, Small Lymphocytic Lymphoma | — | 2013-10-01 |
| Completed | Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. Thrombocytopenia | Phase 2 | 2013-09-16 |
| Completed | Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase Chronic Phase Philadelphia Positive, BCR-ABL Positive, Chronic Myeloid Leukaemia | — | 2013-06-21 |
| Completed | PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism Hematologic Neoplasm, Acute Leukemia, Myelodysplastic Syndrome | — | 2013-06-01 |
| Unknown | Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors Chronic Myeloid Leukemia, Pregnancy | — | 2013-05-02 |
| Completed | Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia Acute Promyelocytic Leukemia | — | 2013-02-01 |
| Completed | Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease Refractory Cold Agglutinin Disease | Phase 2 | 2012-12-01 |
| Completed | Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia | Phase 2 | 2012-10-01 |
| Completed | Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotin Chronic Myeloid Leukaemia | — | 2012-09-13 |
| Terminated | Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients AML, Adult | — | 2012-09-11 |
| Completed | Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study Treatment, Stem Cell Transplantation | Phase 2 | 2012-06-01 |
| Completed | Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemothe Acute Promyelocytic Leukemia, Pregnancy | — | 2012-03-07 |
| Completed | Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 2 | 2012-01-01 |
| Completed | Nilotinib in PH+, BCR-, ABL+ CML Patients Chronic Myeloid Leukemia | Phase 3 | 2012-01-01 |
| Completed | Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pIT Immune Thrombocytopenic Purpura | — | 2011-12-01 |
| Terminated | Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemi Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2011-11-01 |
| Unknown | De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients ALL Ph Positive | Phase 2 | 2011-06-01 |
| Completed | GIMEMA CLL0809 Study (BendOfa) Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or, Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines | Phase 2 | 2010-12-01 |
| Completed | Patient Reported Outcomes in Chronic Myeloid Leukemia Chronic Myeloid Leukemia | — | 2010-11-01 |
| Completed | Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Leukemia | Phase 1 | 2010-10-01 |
| Completed | Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia Leukemia | N/A | 2010-04-01 |
| Completed | Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Chronic Myeloid Leukemia | — | 2010-03-01 |
| Completed | Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia Leukemia | Phase 2 | 2009-02-09 |
| Completed | Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia Leukemia | Phase 2 | 2008-12-01 |
| Unknown | Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes Adult, Myelodysplastic Syndromes | — | 2008-10-02 |
| Completed | Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura Nonneoplastic Condition | Phase 3 | 2008-04-01 |
| Completed | Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therap Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2008-02-01 |
| Completed | "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients Leukemia, Lymphoblastic, Acute | Phase 2 | 2007-11-01 |
| Completed | Phase III Trial in Acute Promyelocytic Leukemia Patients Leukemia | Phase 3 | 2007-08-01 |
| Completed | Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase Chronic Myeloid Leukemia | Phase 2 | 2007-06-23 |
| Completed | Safety, Tolerability, and Efficacy of Deferasirox in MDS Myelodysplastic Syndromes, Hemosiderosis | Phase 3 | 2007-06-01 |
| Completed | Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzum Leukemia | Phase 2 | 2007-05-01 |
| Completed | PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS Myelodysplastic Syndromes | Phase 2 | 2007-05-01 |
| Completed | Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Leukemia | Phase 2 | 2007-03-01 |
| Completed | Treatment of Adult Ph+ LAL With BMS-354825 Lymphoblastic Leukemia, Acute | Phase 2 | 2006-09-01 |
| Terminated | Velcade in Myelodysplastic Syndrome - Pilot Study MDS | Phase 2 | 2006-08-01 |
| Completed | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia Leukemia | Phase 2 | 2004-10-01 |
| Completed | STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia | Phase 2 | 2001-12-01 |
| Completed | DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML AML, Elderly | Phase 3 | 2001-10-01 |
| Completed | Adult ALL Treatment at Diagnosis Leukemia, Lymphocytic, Acute | N/A | 2000-07-01 |
| Unknown | AIDA 2000 Guidelines Acute Promyelocytic Leukemia | Phase 2 | 2000-05-01 |
| Unknown | AML Treatment in Untreated Adult Patients Leukemia, Myelocytic, Acute | N/A | 1998-11-01 |
| Unknown | GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL. Acute Lymphoblastic Leukemia | Phase 2 | 1996-10-01 |
| Unknown | "AIDA" Protocol (LAP 0493) Leukemia | N/A | 1993-10-01 |